[Results of long-term treatment of polycythemia vera with busulfan (Myleran) or dibromomannitol (Myelobromol): analysis of 4 clinical cases observed and treated during more than 7 years].
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002066:Busulfan / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008134:Long-Term Care; D008353:Mannitol / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D011087:Polycythemia Vera / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced
D000970:Antineoplastic Agents; D008353:Mannitol; D002066:Busulfan
Résultats à long terme du traitement de la polycythémie vraie par le busulphan (Myléran) ou le dibromomannitol (Myélobromol): aalyse de quatre cas suivis et traités pendant plus de sept ans.